Literature DB >> 19401331

A splice variant of cyclin D2 regulates cardiomyocyte cell cycle through a novel protein aggregation pathway.

Qian Sun1, Feixiong Zhang, Karim Wafa, Timothy Baptist, Kishore B S Pasumarthi.   

Abstract

The mammalian heart lacks intrinsic ability to replace diseased myocardium with newly divided myocytes. There is scant information on mechanisms regulating cell cycle exit in cardiomyocytes. We cloned a splice variant of cyclin D2 (D2SV) from the mouse heart and found a novel role for this protein in cardiomyocyte cell cycle exit. We report that D2SV is highly expressed in embryonic myocardium compared with the adult heart. Localization studies indicate that D2SV is retained in the endoplasmic reticulum (ER), Golgi and lysosomal compartments and subjected to ER-stress-associated protein aggregation. D2SV aggregation relies on the motor activities of dynein and is blocked by ER stress modulators. The ability of D2SV to sequester other cell cycle proteins provides a mechanistic explanation for its effects on cardiomyocyte cell cycle. We show that D2SV-induced cell cycle exit can be rescued by overexpression of D-type and B-type cyclins. We suggest that protein aggregation may be a major block for cardiomyocyte cell cycle reactivation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401331     DOI: 10.1242/jcs.047738

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  8 in total

1.  Co-expressed Cyclin D variants cooperate to regulate proliferation of germline nuclei in a syncytium.

Authors:  Gunasekaran Subramaniam; Coen Campsteijn; Eric M Thompson
Journal:  Cell Cycle       Date:  2015-04-30       Impact factor: 4.534

2.  Effects of β-adrenergic receptor drugs on embryonic ventricular cell proliferation and differentiation and their impact on donor cell transplantation.

Authors:  Tiam Feridooni; Adam Hotchkiss; Mark Baguma-Nibasheka; Feixiong Zhang; Brittney Allen; Sarita Chinni; Kishore B S Pasumarthi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-10       Impact factor: 4.733

Review 3.  Binucleation of cardiomyocytes: the transition from a proliferative to a terminally differentiated state.

Authors:  Alexandra N Paradis; Maresha S Gay; Lubo Zhang
Journal:  Drug Discov Today       Date:  2013-10-31       Impact factor: 7.851

4.  Cardiomyocyte specific ablation of p53 is not sufficient to block doxorubicin induced cardiac fibrosis and associated cytoskeletal changes.

Authors:  Tiam Feridooni; Adam Hotchkiss; Sarah Remley-Carr; Yumiko Saga; Kishore B S Pasumarthi
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

Review 5.  Maturation of pluripotent stem cell derived cardiomyocytes: The new challenge.

Authors:  Idil Aigha; Christophe Raynaud
Journal:  Glob Cardiol Sci Pract       Date:  2016-03-31

6.  Regulation of Transplanted Cell Homing by FGF1 and PDGFB after Doxorubicin Myocardial Injury.

Authors:  Mark Baguma-Nibasheka; Tiam Feridooni; Feixiong Zhang; Kishore B S Pasumarthi
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

7.  Characterization of growth suppressive functions of a splice variant of cyclin D2.

Authors:  Karim Wafa; Jessica MacLean; Feixiong Zhang; Kishore B S Pasumarthi
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

8.  SCaMC-1Like a member of the mitochondrial carrier (MC) family preferentially expressed in testis and localized in mitochondria and chromatoid body.

Authors:  Ignacio Amigo; Javier Traba; Jorgina Satrústegui; Araceli del Arco
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.